Aker BioMarine AS
Stock Forecast, Prediction & Price Target
Aker BioMarine AS Financial Estimates
Aker BioMarine AS Revenue Estimates
Aker BioMarine AS EBITDA Estimates
Aker BioMarine AS Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| NOK262.06M N/A | NOK277.2M 5.77% | NOK335.3M 20.95% | Avg: NOK428.71M Low: NOK393.20M High: NOK477.99M avg. 27.85% | Avg: NOK468.25M Low: NOK426.37M High: NOK509.83M avg. 9.22% | Avg: NOK454.37M Low: NOK413.73M High: NOK494.71M avg. -2.96% | Avg: NOK477.14M Low: NOK434.46M High: NOK519.51M avg. 5.01% |
Net Income
% change YoY
| NOK-8.00M N/A | NOK10M 224.87% | NOK-9M -190% | Avg: NOK29.29M Low: NOK87.48K High: NOK4.13M avg. 425.51% | Avg: NOK43.68M Low: NOK848.54K High: NOK5.93M avg. 49.10% | Avg: NOK0 Low: NOK0 High: NOK0 avg. -100% | Avg: NOK0 Low: NOK0 High: NOK0 avg. 0% |
EBITDA
% change YoY
| NOK56.92M N/A | NOK75.6M 32.80% | NOK49.7M -34.25% | Avg: NOK85.83M Low: NOK78.72M High: NOK95.69M avg. 72.70% | Avg: NOK93.74M Low: NOK85.36M High: NOK102.07M avg. 9.22% | Avg: NOK90.97M Low: NOK82.83M High: NOK99.04M avg. -2.96% | Avg: NOK95.52M Low: NOK86.98M High: NOK104.01M avg. 5.01% |
EPS
% change YoY
| -$0.09 N/A | $0.11 220.35% | -$0.1 -190.90% | Avg: $0.02 Low: $0 High: $0.05 avg. 121.06% | Avg: $0.04 Low: $0.01 High: $0.07 avg. 83.83% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
Operating Expenses
% change YoY
| NOK102.15M N/A | NOK95.6M -6.41% | NOK107.6M 12.55% | Avg: NOK124.10M Low: NOK113.82M High: NOK138.36M avg. 15.33% | Avg: NOK135.54M Low: NOK123.42M High: NOK147.58M avg. 9.22% | Avg: NOK131.53M Low: NOK119.76M High: NOK143.21M avg. -2.96% | Avg: NOK138.12M Low: NOK125.76M High: NOK150.38M avg. 5.01% |
FAQ
What is Aker BioMarine AS stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 118.65% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is 87.48K, average is 29.29M and high is 4.13M.
What is Aker BioMarine AS stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.78% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is NOK393.20M, average is NOK428.71M and high is NOK477.99M.
What is Aker BioMarine AS stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 51.22% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is $0, average is $0.02 and high is NOK0.04.